Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway

Journal of Lipid Research

Volumn 40, Issue 2, 1999, Pages 275-286

  White, Ann L ^a,b   Guerra, Bernadette ^c   Wang, Jin ^b   Lanford, Robert E ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Apolipoprotein a ; Calnexin; Endoplasmic reticulum; Proteasome; Ubiquitin

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; BREFELDIN A; CHAPERONE; GLUCOSAMINIDASE; HEMAGGLUTININ; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN; ACETYLCYSTEINE; ACETYLLEUCYL LEUCYL NORLEUCINAL; ACETYLLEUCYL-LEUCYL-NORLEUCINAL; BETA N ACETYLHEXOSAMINIDASE; CALNEXIN; CYSTEINE PROTEINASE; DRUG DERIVATIVE; LEUPEPTIN; MANNOSIDASE; MULTIENZYME COMPLEX;

ALLELE; ANIMAL CELL; ARTICLE; BABOON; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENE; GOLGI COMPLEX; IMMUNOPRECIPITATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENETIC TRANSFECTION; LEGUME; LIVER CELL; METABOLISM; PAPIO; PHYSIOLOGY; PROTEIN PROCESSING; SECRETION; SERODIAGNOSIS;

ACETYLCYSTEINE; ANIMALS; APOLIPOPROTEINS A; CALNEXIN; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPLASMIC RETICULUM; FABACEAE; HEPATOCYTES; HEXOSAMINIDASES; LEUPEPTINS; MANNOSIDASES; MOLECULAR CHAPERONES; MULTIENZYME COMPLEXES; PAPIO; PRECIPITIN TESTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSFECTION; UBIQUITIN;

EID: 0032913406     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Makino, K., and A. M. Scanu. 1991. Lipoprotein[a]: nonhuman primate models. Lipids. 26: 679-68.
2. Laplaud, P. M., L. Beaubatie, S. C. Rall, Jr., G. Luc, and M. Sahoureau. 1988. Lipoprotein [a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J. Lipid Res. 29: 1157-1170.
3. Utermann, G. 1989. The mysteries of hpoprotein[a]. Science. 246: 904-910.
4. Kraft, H. G., H. J. Menzel, F. Hoppichler, W. Vogel, and G. Utermann. 1989. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J. Clin. Invest. 83: 137-142.
5. Tomlinson, J. E., J. W. McLean, and R. M. Lawn. 1989. Rhesus monkey apolipoprotein[a]. Sequence, evolution, and sites of synthesis. J. Biol. Chem. 264: 5957-5965.
6. Rainwater, D. L., and R. E. Lanford. 1989. Production of lipoprotein[a] by primary baboon hepatocytes. Biochim. Biophys. Acta. 1003: 30-35.
7. While, A. L., D. L. Rainwater, and R. E. Lanford. 1993. Intracellular maturation of apolipoprotein [a] and assembly of lipoprotein [a] in primary baboon hepatocytes. J. Lipid Res. 34: 509-517.
8. White, A. L., and R. E. Lanford. 1994. Cell surface assembly of lipoprotein [a] in primary cultures of baboon hepatocytes. J. Biol. Chem. 269: 28716-28723.
9. Chiesa, G., H. H. Hobbs, M. L. Koscbinsky, R. M. Lawn, S. D. Maika, and R. E. Hammer. 1992. Reconstitution of lipoprotein [a] by infusion of human low density Lipoprotein into transgenic mice expressing human apolipoprotein [a]. J. Biol. Chem. 34: 24369-24374.
10. Gaubatz, J. W., G. L. Cushing, and J. D. Morrisett. 1986. Quantitation, isolation, and characterization of human lipoprotein [a]. Methods Enzymol. 129: 167-186.
11. Krempler, F., G. M. Kostner, and K. Bolzano. 1980. Turnover of lipoprotein [a] in man. J. Clin. Invest. 65: 1483-1490.
12. Rader, D. J., W. Cain, K. Ikewaki, G. Talley, L. A. Zech, D. Usher, and H. B. Brewer, Jr. 1994. The inverse association of plasma lipoprotein[a] concentrations with apolipoprotein [a] isoform size is not due to differences in Lp[a] catabolism but to differences in production rate. J. Clin. Invest, 93: 2758-2763.
13. Scanu, A. M., and G. M. Fless. 1990. Lipoprotein [a]. Heterogeneity and biological relevance. J. Clin. Invest. 85: 1709-1715.
14. McLean, J. W., J. E. Tomlinson, W. Kuang, D. L. Eaton, E. Y. Chen, G. M. Fless, A. M. Scanu, and R. M. Lawn. 1987. cDNA sequence of human apolipoprotein [a] is homologous to plasminogen. Nature. 330: 132-137.
15. Lackner, C., J. C. Cohen, and H. H. Hobbs. 1993. Molecular definition of the extreme size polymorphism in apolipoprotein[a]. Hum. Mol. Genet. 2: 933-940.
16. Cohen, J. C., G. Chiesa, and H. H. Hobbs. 1993. Sequence polymorphisms in the apolipoprotein [a] gene. Evidence for dissociation between apolipoprotein[a] size and plasma lipoprotein[a] levels. J. Clin. Invest. 91: 1630-1636.
17. Boerwinkle, E., C. C. Leffert, J. Lin, C. Lackner, G. Chiesa, and H.H. Hobbs. 1992. Apolipoprotein [a] gene accounts for greater than 90% of the variation in plasma lipoprotein [a] concentrations. J. Clin. Invest. 90: 52-60.
18. Utermann, G., H. J. Menzel. H. G. Kraft, H. C. Duba, H. G. Kemmler, and C. Seitz. 1987. Lp[a] glycoprotein phenotypes. Inheritance and relation to Lp[a]-lipoprotcm concentrations in plasma. J. Clin, Invest. 80: 458-465.
19. Gaubatz, J. W., K. I. Ghanem, J. Guevara, Jr., M. L. Nava, W. Patsch, and J. D. Morrisett. 1990. Polymorphic forms of human apolipoprotein [a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein [a]. J. Lipid Res. 31: 603-613.
20. Marcovina, S. M., Z. H. Zhang, V. P. Gaur, and J. J. Albers. 1993. Identification of 34 apolipoprotein[a] isoforms: differential expression of apolipoproteinf[a] alleles betwreen American Blacks and Whites. Biochim. Biophys. Res. Commun. 191: 1192-1196.
21. Lackner, C., E. Boerwinkle, C. C. Leffert, T. Rahmig, and H. H. Hobbs. 1991. Molecular basis of apolipoprotein [a] isoform size heterogeneity as revealed by pulserd-field gel elertrophoresis. J. Clin. Invest, 87: 2153-2161.
22. Perombelon, Y. F. N., A. K. Soutar, and B. L. Knight. 1994. Variation in lipoprotein [a] concentration associated with different apolipoprotein[a] alleles. J. Clin. Invest. 93: 1481-1492.
23. White, A. L., J. E. Hixson, D. L. Rainwater, and R. E. Lanford. 1994. Molecular basis for "null" lipoprotein [a] phenotypes and the influence of apolipoprotein [a] size on plasma lipoprotein [a] level in the baboon. J. Biol. Chem. 269: 9060-9066.
24. Kraft, H. G., A. Lingenhel, R. W. C. Pang, R. Delport, M. Tromnisdorff, H. Vermaak, E. D. Janus, and G. Utermann. 1996. Frequency distributions of apolipoprotein[a] kringle IV repeal alleles and their effects on lipoprotein[a] levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur. J. Hum. Genet. 4: 74-87.
25. Mancini, F. P., V. Mooser, R. Guerra, and H. H. Hobhs. 1995. Sequence microheterogeneity in apolipoprotein[a] gene repeats and the relationship to plasma Lp[a] levels. Hum Mol. Genet. 4: 1535-1542.
26. Rainwater, D. L., G. S. Manis, and R. S. Kushwaha. 1986. Characterization of an unusual lipoprotein similar to human lipoprotein a isolated from the baboon, Papio sp. Biochim. Biophys. Acta. 877: 75-78.
27. Rainwater, D. L., G. S. Manis, and J. L. VandeBerg. 1989. Hereditary and dietary effects on apolipoprotein [a] isoforms and Lp[a] in baboons. J. Lipid Res. 30: 549-558.
28. Lanford, R. K., L. Estlack, and A. L. White. 1996. Neomycin inhibits secretion of apolipoprotein [a] by increasing retention on the hepatocyte cell surface. J Lipid. 37: 2055-2064.
29. White, A. L., B. Guerra, and R. E. Lanford. 1997. Influence of allelic variation on apolipoprotein [a] folding in the endoplasmic reticulum. J. Biol. Chem. 272: 5048-5055.
30. Treier, M., L. M. Staszewski, and D. Bohman. 1994. Ubiquitindependent c-Jun degradation in vivo is mediated by the δ-domain. Cell. 78: 787-798.
31. Lanford, R. E., K. D. Carey, L. K. Estlack, G. G. Smith, and R. V. Hay. 1989. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell Dev. Biol. 25: 174-182.
32. Meigs, T. E., and R. D. Simoni. 1992. Regulated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in permeabilized cells. J. Biol. Chem. 267: 13547-13552.
33. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78: 761-771.
34. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific ainino-terminal threonine modification by laclacystin. Science. 268: 726-731.
35. Fisher, E. A., M. Zhou, D. M. Mitchell, X. Wu, S. Omura, H. Wang, A. L. Goldberg, and H. N. Ginsberg. 1997. The degradation of apolipoprotein B-100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70. J. Biol. Chem. 272: 20427-20434.
36. Wiertz, E. J. H. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature. 384: 432-438.
37. Werner, E. D., J. L. Brodsky, and A. A. McCracken. 1996. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA. 93: 13797-13801.
38. Plemper, R K., S. Bohmler, J. Bordallo, T. Sommer, and D. H. Wolf. 1997. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation, nature. 388: 891-895.
39. Ciechanover, A. 1994. The ubiquitin-proteasome degradation pathway. Cell. 79: 13-21.
40. Tarentino, A. L., T. H. Plummer, Jr., and F. Maley. 1974. The release of intact oligosaccharides from specific glycoproteins by endo-B-N-acetylglucosaminidase H. J. Biol. Chem. 249: 818-824.
41. Furukawa, S., N. Sakata, H. N. Ginsberg, and J. L. Dixon. 1992. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells. J. Biol. Chem. 267: 22630-22638.
42. Klausner, R. D., J. G. Donaldsou, and J. Lippincott-Schwartz. 1992. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol. 116: 1071-1080.
43. Raposo, G., H. M. Van Santen, R. Leijendekker, H. J. Geuze, and H. I., Ploegh. 1990. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 131: 1403-1419.
44. Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54: 631-664.
45. Sousa, M., and A. J. Parodi. 1995. The molecular basis for the recognition of misfolded glycoproteins by the UDP-Gk:glycoprotein glucosyltiansferase. EMBO J. 14: 4196-4203.
46. Moore, S. E. H., and R. G. Spiro. 1993. Inhibition of glucose trimming by castanospermine results in rapid degradation of unassembled major histocompatibility complex class I molecules. J. Biol. Chem. 268: 3809-3812.
47. Hebert, D. N., B. Foellmer, and A. Helenius. 1996. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J. 15: 2961-2968.
48. Fuhrmann, U., E. Bause, and H. Pleogh. 1985. Inhibitors of oligosaccharide processing. Biochim. Biophys. Acta. 825: 95-110.
49. Hebert, D. N., B. Foellmer, and A. Helenius. 1995. Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reuculum. Cell. 81: 425-433.
50. Hammond, C., I. Braakman, and A. Helenius. 1994. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA. 91: 913-917.
51. Qu, D. F., J. H. Teckman, S. Omura, and D. H. Perlmutter. 1996. Degradation of a mutant secretory protein, α1-antilrypsin Z, in the endoplasmic reticulum requires proleasome activity. J. Biol. Chem. 271: 22791-22795.
52. McCracken, A. A., and J. L. Brodsky. 1996. Assembly of ER-associated protein degradation in vitro, dependence on cytosol, calnexin, and ATP. J. Cell Biol. 132: 291-298.
53. Noiva, R., and W. J. Lennarz. 1992. Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum. J. Biol. Chem. 267: 3553-3556.
54. Biederer, T., C. Volkwein, and T. Sommer. 1997. Role of cue1p in ubiquitination and degradation at the ER surface. Science. 278: 1806-1809.
55. Mayer, T. U., T. Braun, and S. Jentsch. 1998. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J. 17: 3251-3257.
56. Nassir, F., D. K. Bonen, and N. O. Davidson. 1998. Apolipoprotein [a] synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion. J. Biol. Chem. 273: 17793-17800.
57. Le, A., G. A. Ferrell, D. S. Dishon, A. Q. Le, and R. N. Sifers. 1992. Soluble aggregates of the human PiZ α1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. J. Biol. Chem. 267: 1072-1080.
58. Van Leeuwen, J. E. M., and K. P. Kearse. 1996. The related molecular chaperones calnexin and calreticulin differentially associate with nascent T cell antigen receptor proteins within the endoplasmic reticulum. J. Biol. Chem. 271: 25345-25349.
59. Oliver, J. D., F.J. van der Wal, N.J. Bulleid, and S. High. 1997. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science. 275: 86-88.